Omnicell Debt to Equity Ratio 2010-2023 | OMCL
Current and historical debt to equity ratio values for Omnicell (OMCL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Omnicell debt/equity for the three months ending December 31, 2023 was 0.48.
| Omnicell Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-12-31 |
$1.04B |
$1.19B |
0.87 |
| 2023-09-30 |
$1.03B |
$1.19B |
0.87 |
| 2023-06-30 |
$1.03B |
$1.16B |
0.89 |
| 2023-03-31 |
$1.11B |
$1.14B |
0.97 |
| 2022-12-31 |
$1.08B |
$1.13B |
0.96 |
| 2022-09-30 |
$1.04B |
$1.14B |
0.92 |
| 2022-06-30 |
$1.04B |
$1.09B |
0.95 |
| 2022-03-31 |
$1.05B |
$1.08B |
0.98 |
| 2021-12-31 |
$1.00B |
$1.15B |
0.87 |
| 2021-09-30 |
$0.94B |
$1.11B |
0.85 |
| 2021-06-30 |
$0.91B |
$1.05B |
0.86 |
| 2021-03-31 |
$0.88B |
$1.01B |
0.87 |
| 2020-12-31 |
$0.86B |
$0.97B |
0.89 |
| 2020-09-30 |
$0.80B |
$0.92B |
0.87 |
| 2020-06-30 |
$0.34B |
$0.89B |
0.38 |
| 2020-03-31 |
$0.35B |
$0.88B |
0.40 |
| 2019-12-31 |
$0.40B |
$0.85B |
0.47 |
| 2019-09-30 |
$0.44B |
$0.81B |
0.54 |
| 2019-06-30 |
$0.42B |
$0.77B |
0.55 |
| 2019-03-31 |
$0.45B |
$0.73B |
0.61 |
| 2018-12-31 |
$0.40B |
$0.68B |
0.59 |
| 2018-09-30 |
$0.43B |
$0.62B |
0.70 |
| 2018-06-30 |
$0.44B |
$0.59B |
0.74 |
| 2018-03-31 |
$0.47B |
$0.58B |
0.81 |
| 2017-12-31 |
$0.46B |
$0.55B |
0.83 |
| 2017-09-30 |
$0.45B |
$0.47B |
0.96 |
| 2017-06-30 |
$0.46B |
$0.45B |
1.02 |
| 2017-03-31 |
$0.47B |
$0.44B |
1.07 |
| 2016-12-31 |
$0.50B |
$0.43B |
1.17 |
| 2016-09-30 |
$0.50B |
$0.43B |
1.18 |
| 2016-06-30 |
$0.50B |
$0.41B |
1.21 |
| 2016-03-31 |
$0.51B |
$0.41B |
1.25 |
| 2015-12-31 |
$0.18B |
$0.40B |
0.44 |
| 2015-09-30 |
$0.19B |
$0.39B |
0.47 |
| 2015-06-30 |
$0.20B |
$0.40B |
0.51 |
| 2015-03-31 |
$0.17B |
$0.41B |
0.41 |
| 2014-12-31 |
$0.17B |
$0.39B |
0.44 |
| 2014-09-30 |
$0.17B |
$0.38B |
0.44 |
| 2014-06-30 |
$0.16B |
$0.38B |
0.42 |
| 2014-03-31 |
$0.15B |
$0.37B |
0.40 |
| 2013-12-31 |
$0.14B |
$0.35B |
0.41 |
| 2013-09-30 |
$0.15B |
$0.36B |
0.41 |
| 2013-06-30 |
$0.14B |
$0.33B |
0.42 |
| 2013-03-31 |
$0.14B |
$0.32B |
0.42 |
| 2012-12-31 |
$0.13B |
$0.31B |
0.44 |
| 2012-09-30 |
$0.13B |
$0.30B |
0.42 |
| 2012-06-30 |
$0.12B |
$0.29B |
0.41 |
| 2012-03-31 |
$0.08B |
$0.29B |
0.29 |
| 2011-12-31 |
$0.08B |
$0.28B |
0.29 |
| 2011-09-30 |
$0.08B |
$0.28B |
0.29 |
| 2011-06-30 |
$0.08B |
$0.27B |
0.29 |
| 2011-03-31 |
$0.08B |
$0.27B |
0.29 |
| 2010-12-31 |
$0.08B |
$0.27B |
0.29 |
| 2010-09-30 |
$0.08B |
$0.26B |
0.30 |
| 2010-06-30 |
$0.08B |
$0.26B |
0.30 |
| 2010-03-31 |
$0.08B |
$0.25B |
0.32 |
| 2009-12-31 |
$0.08B |
$0.24B |
0.33 |
| 2009-09-30 |
$0.08B |
$0.24B |
0.32 |
| 2009-06-30 |
$0.08B |
$0.24B |
0.32 |
| 2009-03-31 |
$0.07B |
$0.24B |
0.30 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$1.260B |
$1.147B |
|
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
|
